发明名称 METHODS FOR MODULATING FACTOR 12 EXPRESSION
摘要 Disclosed herein are methods for decreasing Factor 12 and treating or preventing thromboembolic conditions in an individual in need thereof. Examples of disease conditions that can be ameliorated with the administration of antisense compounds targeted to Factor 12 include thrombosis, embolism, and thromboembolism, such as, deep vein thrombosis, pulmonary embolism, myocardial infarction, stroke, and mesenteric thrombosis. Methods for inhibiting Factor 12 can also be used as a prophylactic treatment to prevent individuals at risk for thrombosis and embolism.
申请公布号 WO2012064758(A2) 申请公布日期 2012.05.18
申请号 WO2011US59804 申请日期 2011.11.08
申请人 ISIS PHARMACEUTICALS, INC.;MONIA, BRETT, P.;MACLEOD, ROBERT, A.;CROSBY, JEFFREY, R. 发明人 MONIA, BRETT, P.;MACLEOD, ROBERT, A.;CROSBY, JEFFREY, R.
分类号 A61K48/00 主分类号 A61K48/00
代理机构 代理人
主权项
地址